AMRIZE LTD (AMRZ) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AMRZ • CH1430134226

58.94 USD
-1.22 (-2.03%)
At close: Feb 11, 2026
58.94 USD
0 (0%)
After Hours: 2/11/2026, 8:06:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMRZ. AMRZ was compared to 13 industry peers in the Construction Materials industry. AMRZ has a bad profitability rating. Also its financial health evaluation is rather negative. AMRZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • AMRZ had positive earnings in the past year.
AMRZ Yearly Net Income VS EBIT VS OCF VS FCFAMRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • AMRZ's Return On Assets of 5.30% is in line compared to the rest of the industry. AMRZ outperforms 46.15% of its industry peers.
  • With a Return On Equity value of 9.88%, AMRZ is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
  • AMRZ has a Return On Invested Capital (7.43%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 5.3%
ROE 9.88%
ROIC 7.43%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMRZ Yearly ROA, ROE, ROICAMRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • AMRZ has a better Profit Margin (10.89%) than 61.54% of its industry peers.
  • AMRZ has a better Operating Margin (18.16%) than 69.23% of its industry peers.
  • AMRZ has a Gross Margin of 26.23%. This is in the lower half of the industry: AMRZ underperforms 69.23% of its industry peers.
Industry RankSector Rank
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMRZ Yearly Profit, Operating, Gross MarginsAMRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMRZ is destroying value.
  • Compared to 1 year ago, AMRZ has about the same amount of shares outstanding.
  • AMRZ has a better debt/assets ratio than last year.
AMRZ Yearly Shares OutstandingAMRZ Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M 500M
AMRZ Yearly Total Debt VS Total AssetsAMRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 2.68 indicates that AMRZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of AMRZ (2.68) is comparable to the rest of the industry.
  • AMRZ has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
  • AMRZ has a Debt to Equity ratio of 0.45. This is comparable to the rest of the industry: AMRZ outperforms 53.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 2.68
ROIC/WACC0.73
WACC10.19%
AMRZ Yearly LT Debt VS Equity VS FCFAMRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.45 indicates that AMRZ should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.45, AMRZ is doing worse than 69.23% of the companies in the same industry.
  • AMRZ has a Quick Ratio of 1.45. This is a bad value and indicates that AMRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.97, AMRZ is doing worse than 69.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.97
AMRZ Yearly Current Assets VS Current LiabilitesAMRZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.26% over the past year.
  • The Revenue has been growing slightly by 0.23% in the past year.
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, AMRZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.65% on average per year.
  • Based on estimates for the next years, AMRZ will show a small growth in Revenue. The Revenue will grow by 5.04% on average per year.
EPS Next Y2.39%
EPS Next 2Y9.09%
EPS Next 3Y10.61%
EPS Next 5Y11.65%
Revenue Next Year3.3%
Revenue Next 2Y3.78%
Revenue Next 3Y4.43%
Revenue Next 5Y5.04%

3.3 Evolution

AMRZ Yearly Revenue VS EstimatesAMRZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
AMRZ Yearly EPS VS EstimatesAMRZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • AMRZ is valuated quite expensively with a Price/Earnings ratio of 25.63.
  • The rest of the industry has a similar Price/Earnings ratio as AMRZ.
  • AMRZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.23.
  • Based on the Price/Forward Earnings ratio of 21.49, the valuation of AMRZ can be described as rather expensive.
  • AMRZ's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, AMRZ is valued a bit cheaper.
Industry RankSector Rank
PE 25.63
Fwd PE 21.49
AMRZ Price Earnings VS Forward Price EarningsAMRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMRZ indicates a somewhat cheap valuation: AMRZ is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.66
AMRZ Per share dataAMRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMRZ does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)10.74
PEG (5Y)N/A
EPS Next 2Y9.09%
EPS Next 3Y10.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AMRZ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMRIZE LTD

NYSE:AMRZ (2/11/2026, 8:06:20 PM)

After market: 58.94 0 (0%)

58.94

-1.22 (-2.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)10-28
Earnings (Next)02-17
Inst Owners50.99%
Inst Owner ChangeN/A
Ins Owners7.22%
Ins Owner Change41.87%
Market Cap32.60B
Revenue(TTM)11.70B
Net Income(TTM)1.27B
Analysts76.47
Price TargetN/A
Short Float %1.94%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.79%
Min EPS beat(2)-33.5%
Max EPS beat(2)3.92%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)-1.97%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-39.44%
EPS NQ rev (3m)-44.16%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-3.24%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 25.63
Fwd PE 21.49
P/S 2.79
P/FCF N/A
P/OCF N/A
P/B 2.53
P/tB 15.19
EV/EBITDA 12.66
EPS(TTM)2.3
EY3.9%
EPS(NY)2.74
Fwd EY4.65%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.16
BVpS23.33
TBVpS3.88
PEG (NY)10.74
PEG (5Y)N/A
Graham Number34.74
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 9.88%
ROCE 10.18%
ROIC 7.43%
ROICexc 7.72%
ROICexgc 16.16%
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 1.93
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.97
Altman-Z 2.68
F-ScoreN/A
WACC10.19%
ROIC/WACC0.73
Cap/Depr(3y)69.39%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)137.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y2.39%
EPS Next 2Y9.09%
EPS Next 3Y10.61%
EPS Next 5Y11.65%
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.3%
Revenue Next 2Y3.78%
Revenue Next 3Y4.43%
Revenue Next 5Y5.04%
EBIT growth 1Y13.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.34%
EBIT Next 3Y18.7%
EBIT Next 5Y14.31%
FCF growth 1Y16.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.08%
OCF growth 3YN/A
OCF growth 5YN/A

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

ChartMill assigns a fundamental rating of 2 / 10 to AMRZ.


What is the valuation status of AMRIZE LTD (AMRZ) stock?

ChartMill assigns a valuation rating of 2 / 10 to AMRIZE LTD (AMRZ). This can be considered as Overvalued.


What is the profitability of AMRZ stock?

AMRIZE LTD (AMRZ) has a profitability rating of 2 / 10.


What is the financial health of AMRIZE LTD (AMRZ) stock?

The financial health rating of AMRIZE LTD (AMRZ) is 3 / 10.